AsymBio Expands Biologics CDMO with New Shanghai R&D Center July 27, 2026 by Mathieu Maurice AsymBio, the biologics-focused Contract Development and Manufacturing Organization (CDMO) under the Asymchem Group (stock codes: 002821.SZ / 6821.HK), has announced the groundbreaking of a new research and development facility at …